324 related articles for article (PubMed ID: 23921130)
1. Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.
Caino MC; Chae YC; Vaira V; Ferrero S; Nosotti M; Martin NM; Weeraratna A; O'Connell M; Jernigan D; Fatatis A; Languino LR; Bosari S; Altieri DC
J Clin Invest; 2013 Jul; 123(7):2907-20. PubMed ID: 23921130
[TBL] [Abstract][Full Text] [Related]
2. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
[TBL] [Abstract][Full Text] [Related]
3. Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.
Chae YC; Caino MC; Lisanti S; Ghosh JC; Dohi T; Danial NN; Villanueva J; Ferrero S; Vaira V; Santambrogio L; Bosari S; Languino LR; Herlyn M; Altieri DC
Cancer Cell; 2012 Sep; 22(3):331-44. PubMed ID: 22975376
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of ULK1 by AMPK regulates translocation of ULK1 to mitochondria and mitophagy.
Tian W; Li W; Chen Y; Yan Z; Huang X; Zhuang H; Zhong W; Chen Y; Wu W; Lin C; Chen H; Hou X; Zhang L; Sui S; Zhao B; Hu Z; Li L; Feng D
FEBS Lett; 2015 Jul; 589(15):1847-54. PubMed ID: 25980607
[TBL] [Abstract][Full Text] [Related]
5. Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy.
Joo JH; Dorsey FC; Joshi A; Hennessy-Walters KM; Rose KL; McCastlain K; Zhang J; Iyengar R; Jung CH; Suen DF; Steeves MA; Yang CY; Prater SM; Kim DH; Thompson CB; Youle RJ; Ney PA; Cleveland JL; Kundu M
Mol Cell; 2011 Aug; 43(4):572-85. PubMed ID: 21855797
[TBL] [Abstract][Full Text] [Related]
6. Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth.
Agarwal E; Altman BJ; Seo JH; Ghosh JC; Kossenkov AV; Tang HY; Krishn SR; Languino LR; Gabrilovich DI; Speicher DW; Dang CV; Altieri DC
J Biol Chem; 2019 Jul; 294(27):10407-10414. PubMed ID: 31097545
[TBL] [Abstract][Full Text] [Related]
7. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells.
Siegelin MD; Dohi T; Raskett CM; Orlowski GM; Powers CM; Gilbert CA; Ross AH; Plescia J; Altieri DC
J Clin Invest; 2011 Apr; 121(4):1349-60. PubMed ID: 21364280
[TBL] [Abstract][Full Text] [Related]
8. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.
Guo Z; Peng G; Li E; Xi S; Zhang Y; Li Y; Lin X; Li G; Wu Q; He J
Sci Rep; 2017 Sep; 7(1):10612. PubMed ID: 28878291
[TBL] [Abstract][Full Text] [Related]
9. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.
Kim H; Yang J; Kim MJ; Choi S; Chung JR; Kim JM; Yoo YH; Chung J; Koh H
J Biol Chem; 2016 Jan; 291(4):1841-1853. PubMed ID: 26631731
[TBL] [Abstract][Full Text] [Related]
10. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR.
Egan D; Kim J; Shaw RJ; Guan KL
Autophagy; 2011 Jun; 7(6):643-4. PubMed ID: 21460621
[TBL] [Abstract][Full Text] [Related]
11. The association of AMPK with ULK1 regulates autophagy.
Lee JW; Park S; Takahashi Y; Wang HG
PLoS One; 2010 Nov; 5(11):e15394. PubMed ID: 21072212
[TBL] [Abstract][Full Text] [Related]
12. Landscape of the mitochondrial Hsp90 metabolome in tumours.
Chae YC; Angelin A; Lisanti S; Kossenkov AV; Speicher KD; Wang H; Powers JF; Tischler AS; Pacak K; Fliedner S; Michalek RD; Karoly ED; Wallace DC; Languino LR; Speicher DW; Altieri DC
Nat Commun; 2013; 4():2139. PubMed ID: 23842546
[TBL] [Abstract][Full Text] [Related]
13. Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer.
Xiong Y; He L; Shay C; Lang L; Loveless J; Yu J; Chemmalakuzhy R; Jiang H; Liu M; Teng Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):122. PubMed ID: 30867003
[TBL] [Abstract][Full Text] [Related]
14. ULK1/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy.
Li TY; Sun Y; Liang Y; Liu Q; Shi Y; Zhang CS; Zhang C; Song L; Zhang P; Zhang X; Li X; Chen T; Huang HY; He X; Wang Y; Wu YQ; Chen S; Jiang M; Chen C; Xie C; Yang JY; Lin Y; Zhao S; Ye Z; Lin SY; Chiu DT; Lin SC
Mol Cell; 2016 May; 62(3):359-370. PubMed ID: 27153534
[TBL] [Abstract][Full Text] [Related]
15. Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins.
Li R; Yuan F; Fu W; Zhang L; Zhang N; Wang Y; Ma K; Li X; Wang L; Zhu WG; Zhao Y
J Biol Chem; 2017 Feb; 292(7):2830-2841. PubMed ID: 28073914
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
17. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
18. Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates.
Egan DF; Chun MG; Vamos M; Zou H; Rong J; Miller CJ; Lou HJ; Raveendra-Panickar D; Yang CC; Sheffler DJ; Teriete P; Asara JM; Turk BE; Cosford ND; Shaw RJ
Mol Cell; 2015 Jul; 59(2):285-97. PubMed ID: 26118643
[TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.
Shen Q; Xu Z; Xu S
Int J Oncol; 2020 Oct; 57(4):967-979. PubMed ID: 32945379
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer.
Ono N; Yamazaki T; Tsukaguchi T; Fujii T; Sakata K; Suda A; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
Cancer Sci; 2013 Oct; 104(10):1346-52. PubMed ID: 23863134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
